Related Experiment Video
Updated: Jul 12, 2026
09:45
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
A vascular connection to Alzheimer's disease
1Department of Anatomy, College of Medicine, University of South Florida, Tampa, FL 33612, USA. jrhodin@hsc.usf.edu
Microcirculation (New York, N.Y. : 1994)
|August 31, 2001
Summary
Alzheimer's disease (AD) involves brain changes, including amyloid-beta accumulation and vascular damage. Research suggests these vascular changes may precede neuronal damage and dementia in AD patients.
Area of Science:
- Neuroscience
- Pathology
- Vascular Biology
Background:
- Alzheimer's disease (AD) is a progressive dementia linked to amyloid-beta and Tau protein accumulation.
- Cerebral amyloid angiopathy, characterized by vascular inflammation and amyloid deposits, is a hallmark of AD.
- Current understanding of AD pathogenesis often focuses on neuronal damage, with vascular contributions less emphasized.
Purpose of the Study:
- To investigate vascular responses to amyloid-beta(1-40) infusion in a live animal model.
- To explore methods for preventing vascular damage associated with Alzheimer's disease.
- To examine the temporal relationship between cerebral vascular changes and neuronal damage in AD.
Main Methods:
- Utilized a live rat model to study vascular responses.
- Combined intravital video microscopy of the mesenteric microvascular bed with electron microscopy.
- Administered amyloid-beta(1-40) to assess its impact on vascular integrity.
Main Results:
- Amyloid-beta(1-40) infusion induced significant changes in microvascular beds.
- Electron microscopy revealed inflammation and amyloid accumulation in blood vessels.
- Evidence suggests a breach in the blood-brain barrier following amyloid-beta exposure.
Conclusions:
- Cerebral vascular alterations in Alzheimer's disease may precede the onset of neuronal damage and dementia.
- Targeting vascular pathology could be a potential therapeutic strategy for AD.
- The study provides insights into the early mechanisms of AD pathogenesis involving the vasculature.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...